Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism.
Circulation. 2012 Jan 3;125(1):159-64
Authors: Granger CB, Armaganijan LV
PMID: 22215890 [PubMed - in process]